LOPREEZA

Amneal Pharmaceuticals NY LLC🇺🇸 United States

FDA Page

Effective Date: Jul 25, 2018
Approval ID: 966ac064-9eb7-4d15-b271-a7880ed1e79a
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LOPREEZA safely and effectively. See full prescribing information for LOPREEZA. LOPREEZA (estradiol/norethindrone acetate) tablets, for oral use Initial U.S. Approval: 1998

Quick Stats

Total Products1

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.